Imatinib and altered bone and mineral metabolism.
Joensuu
Heikki
H
Reichardt
Peter
P
D001549:Benzamides; D002118:Calcium / Q000097:blood; D017024:Chemotherapy, Adjuvant; D005500:Follow-Up Studies; D046152:Gastrointestinal Stromal Tumors / Q000188:drug therapy; D006801:Humans; D017674:Hypophosphatemia / Q000139:chemically induced*; D000068877:Imatinib Mesylate; D010710:Phosphates / Q000097:blood; D010879:Piperazines / Q000009:adverse effects*; D047428:Protein Kinase Inhibitors / Q000009:adverse effects*; D011743:Pyrimidines / Q000009:adverse effects*
D001549:Benzamides; D010710:Phosphates; D010879:Piperazines; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D000068877:Imatinib Mesylate; D002118:Calcium